Maxime Dely: What If One Technology Could Transform Patients’ Lives?
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post on LinkedIn:
“Sickle cell disease: What if one technology could transform patients’ lives?
Sickle cell disease is the most common genetic disorder in France, affecting 25,000 to 30,000 people. It remains a complex condition marked by severe pain, microvascular occlusions, strokes, necrosis, jaundice, and episodes of acute hemolytic anemia — all profoundly impacting daily life.
Despite ongoing prevention efforts, the disease continues to progress.
Yet one interventional treatment is truly reshaping patient care: automated red blood cell exchange.
Still underrecognized, this procedure — performed through apheresis systems — brings major benefits supported by numerous studies:
* Drastic reduction in acute crises by removing sickled red cells responsible for vascular occlusion.
* Significantly less iron overload compared with standard transfusion — a crucial long-term advantage.
* Faster procedure, enabling 2 to 3 times more red cell units to be exchanged in the same amount of time.
* More spaced-out sessions, greatly improving comfort and quality of life for patients.
Red blood cell exchange is not just an alternative — it is a major therapeutic advancement for a disease that remains insufficiently visible.
Promoting access to this therapy means offering patients safer, more effective, and more humane care.”
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Apr 6, 2026, 10:49Chokri Ben Lamine: Routine VTE Prophylaxis Is Not Recommended for Chronically Bedridden Patients at Home
-
Apr 6, 2026, 10:03Mohamed Sikkander Abdul Razak: Clinical Steps for Evaluating and Managing Heavy Menstrual Bleeding
-
Apr 6, 2026, 07:14Oliver Tiebel: Antiphospholipid Syndrome in Pregnancy – One of Hematology’s Most Complex Challenges
-
Apr 6, 2026, 06:25Katherine Bridge: My First Time at The EHA ReCon
-
Apr 6, 2026, 06:11Priya Prasad: Family Donations Are Not as Safe as We Usually Think
-
Apr 6, 2026, 05:48Isaac Okello: Turning Point from Reliance on Foreign Exports to Self – Reliance Through Local Production of Medical Supplies
-
Apr 6, 2026, 05:34Lena Volland: Scientific Exchange in Bleeding Disorders at the WFH 2026 World Congress
-
Apr 6, 2026, 04:46Ursula Porage Dona: Bringing the Bleeding Disorders Community Together at WFH 2026 with NNHF
-
Apr 6, 2026, 04:17Arun V J: How War Reshaped Blood Transfusion